home / stock / vivxf / vivxf news

VIVXF News and Press, Avivagen From 08/18/20

Stock Information
Company Name: Avivagen
Stock Symbol: VIVXF
Market: OTC
Website: avivagen.com
Menu
VIVXF VIVXF Quote VIVXF Short VIVXF News VIVXF Articles VIVXF Message Board
Get VIVXF Alerts

News, Short Squeeze, Breakout and More Instantly...
VIVXF - Avivagen Announces Publication of Scientific Paper in British Journal of Nutrition

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and perfor...
VIVXF - Avivagen Announces Payment of Consulting Fee

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and perfor...

VIVXF - Avivagen Secures First Sale of OxC-beta(TM) Livestock in Brazil

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and perfor...

VIVXF - Avivagen: The OxC-beta(TM) Technology Is A True Game Changer

New York, New York--(Newsfile Corp. - July 23, 2020) - Life science stocks are gaining an increasing amount of attention with every passing day as the world continues to battle with the COVID-19 pandemic. Over and above the pharma and biotech players engaged in the development of vaccines and ...
VIVXF - Avivagen Secures Approval for Use of OxC-beta(TM) Livestock in Brazil and Signs Distribution Agreement

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”) a life sciences corporation focused on developing and commercializing immune-system improving products for livestock, companion animal and human applications, is pleased to announce that it has received approval from The Ministr...

VIVXF - Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2020

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta ™ technology, announces its unaudited financial results for the second quarter of 2020. For the three-month ...

VIVXF - Avivagen Announces Increase in North American OxC-beta(TM) Livestock Order Following Successful Dairy Field Tests

Industrias Melder revises initial order from 300 kgs to 2 tonnes Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”) a life sciences corporation focused on developing and commercializing immune-system improving products for livestock, companion animal and human application...
VIVXF - Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, promote general health and perform...

VIVXF - Avivagen Inc. Announces Stock Option Grants

Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) announces that its Board of Directors has approved the issuance of 555,000 stock options, including 465,000 options granted to officers, directors and investor relations personnel of the Corporation. The op...

Previous 10 Next 10